Unmethylated cytosine-guanine rich oligodinucleutides (CpG ODNs), which act on Toll-like receptor 9 (TLR9), have been shown to be a highly effective means of prophylactic neuroprotection in a mouse model of cerebral ischemia [101]. This evidence concerns the gene TLR9 and brain ischemia.